What are the chances of developing secondary leukemia after previous doxorubicin treatment for breast cancer and now receiving R-CHOP for DLBCL?
Your wife's situation involves prior chemotherapy exposure, which can be a concern. While doxorubicin and other chemotherapy drugs can increase the risk of secondary cancers like Show Full Answer
What are the chances of developing secondary leukemia after previous doxorubicin treatment for breast cancer and now receiving R-CHOP for DLBCL?
Your wife's situation involves prior chemotherapy exposure, which can be a concern. While doxorubicin and other chemotherapy drugs can increase the risk of secondary cancers like leukemia, the specific risk varies based on several factors including:
* The cumulative dose of chemotherapy received
* Time since previous treatment (14 years is significant)
* Individual genetic factors
* Overall health status
People with a personal history of cancer do have a higher risk of developing DLBCL - research shows more than 10 percent of people with previous cancer history develop DLBCL. Additionally, exposure to certain chemotherapy drugs is connected to increased NHL risk.
However, it's important to note that R-CHOP remains the standard first-line treatment for DLBCL and is very effective, with 50-70 percent of people achieving complete remission. The benefits of treating the current DLBCL typically outweigh the potential risks of secondary cancers.
Your wife's oncologist should be monitoring her closely and can discuss her specific risk profile based on her complete treatment history. They may adjust treatment approaches if heart or other concerns arise from previous doxorubicin exposure.
January 22
Join
Your Privacy Choices
